All about Tasigna and Arteriosclerosis

Tasigna (generic: nilotinib), a drug that is prescribed to treat a type of blood cancer known as chronic myeloid leukemia (CML), has been found to cause severe and rapid-onset atherosclerosis, a life-threatening cardiovascular disease characterized by a thickening of the arterial walls. According to an article published in Cardio-Oncology in December 2015, there are reports […]